148 related articles for article (PubMed ID: 29344385)
21. The integration of BRCA testing into oncology clinics.
Percival N; George A; Gyertson J; Hamill M; Fernandes A; Davies E; Rahman N; Banerjee S
Br J Nurs; 2016 Jun; 25(12):690-4. PubMed ID: 27345073
[TBL] [Abstract][Full Text] [Related]
22. Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals.
Stuckey A; Febbraro T; Laprise J; Wilbur JS; Lopes V; Robison K
Am J Clin Oncol; 2016 Aug; 39(4):363-7. PubMed ID: 24710121
[TBL] [Abstract][Full Text] [Related]
23. Mainstream genetic testing for high-grade ovarian, tubal and peritoneal cancers: A tertiary referral centre experience.
Srinivasa S; Bowman M; Titterton L; Harnett P; Brand A; Kirk J; Ragunathan A
Aust N Z J Obstet Gynaecol; 2023 Feb; ():. PubMed ID: 36785489
[TBL] [Abstract][Full Text] [Related]
24. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
[TBL] [Abstract][Full Text] [Related]
25. Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic.
Petzel SV; Vogel RI; Bensend T; Leininger A; Argenta PA; Geller MA
J Genet Couns; 2013 Oct; 22(5):662-73. PubMed ID: 23677535
[TBL] [Abstract][Full Text] [Related]
26. Improving identification of lynch syndrome patients: a comparison of research data with clinical records.
Tan YY; McGaughran J; Ferguson K; Walsh MD; Buchanan DD; Young JP; Webb PM; Obermair A; Spurdle AB;
Int J Cancer; 2013 Jun; 132(12):2876-83. PubMed ID: 23225370
[TBL] [Abstract][Full Text] [Related]
27. Setting a baseline: A 7-year review of referral rates and outcomes for serous ovarian cancer prior to implementation of oncologist mediated genetic testing.
Armel SR; Volenik A; Demsky R; Malcolmson J; Maganti M; McCuaig J
Gynecol Oncol; 2020 Aug; 158(2):440-445. PubMed ID: 32505554
[TBL] [Abstract][Full Text] [Related]
28. Facilitated referral pathway for genetic testing at the time of ovarian cancer diagnosis: uptake of genetic counseling and testing and impact on patient-reported stress, anxiety and depression.
Frey MK; Lee SS; Gerber D; Schwartz ZP; Martineau J; Lutz K; Reese E; Dalton E; Olsen A; Girdler J; Pothuri B; Boyd L; Curtin JP; Levine DA; Blank SV
Gynecol Oncol; 2020 Apr; 157(1):280-286. PubMed ID: 32057464
[TBL] [Abstract][Full Text] [Related]
29. Changing practice: moving to a specialist nurse-led service for BRCA gene testing.
Scott N; O'Sullivan J; Asgeirsson K; Macmillan D; Wilson E
Br J Nurs; 2020 May; 29(10):S6-S13. PubMed ID: 32463748
[TBL] [Abstract][Full Text] [Related]
30. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
[TBL] [Abstract][Full Text] [Related]
31. Key messages for communicating information about BRCA1 and BRCA2 to women with breast or ovarian cancer: Consensus across health professionals and service users.
Jacobs C; Pichert G; Harris J; Tucker K; Michie S
Psychooncology; 2017 Nov; 26(11):1818-1824. PubMed ID: 28101941
[TBL] [Abstract][Full Text] [Related]
32. Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients.
Vergote I; Banerjee S; Gerdes AM; van Asperen C; Marth C; Vaz F; Ray-Coquard I; Stoppa-Lyonnet D; Gonzalez-Martin A; Sehouli J; Colombo N
Eur J Cancer; 2016 Dec; 69():127-134. PubMed ID: 27821315
[TBL] [Abstract][Full Text] [Related]
33. Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities.
Meyer LA; Anderson ME; Lacour RA; Suri A; Daniels MS; Urbauer DL; Nogueras-Gonzalez GM; Schmeler KM; Gershenson DM; Lu KH
Obstet Gynecol; 2010 May; 115(5):945-952. PubMed ID: 20410767
[TBL] [Abstract][Full Text] [Related]
34. Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system.
Muessig KR; Zepp JM; Keast E; Shuster EE; Reyes AA; Arnold B; Ingphakorn C; Gilmore MJ; Kauffman TL; Hunter JE; Knerr S; Feigelson HS; Goddard KAB
Hered Cancer Clin Pract; 2022 Feb; 20(1):7. PubMed ID: 35144679
[TBL] [Abstract][Full Text] [Related]
35. Identification of germline genetic mutations in patients with pancreatic cancer.
Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
[TBL] [Abstract][Full Text] [Related]
36. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
37. Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
Armstrong J; Toscano M; Kotchko N; Friedman S; Schwartz MD; Virgo KS; Lynch K; Andrews JE; Aguado Loi CX; Bauer JE; Casares C; Bourquardez Clark E; Kondoff MR; Molina AD; Abdollahian M; Walker G; Sutphen R
JAMA Oncol; 2015 Dec; 1(9):1251-60. PubMed ID: 26426480
[TBL] [Abstract][Full Text] [Related]
38. Analysis of patient reports on the referral process to two NSW cancer genetic services.
Butel-Simoes GI; Spigelman AD
Fam Cancer; 2014 Sep; 13(3):333-43. PubMed ID: 24648127
[TBL] [Abstract][Full Text] [Related]
39. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
